Accelr8 Begins Private Equity Sale to Address 'Going Concern'

The company said that it is addressing a "going concern" statement made last year by auditors through a previously announced private equity sale.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.